Medline Inc. MDLN
40.91 USD +0.20 (+0.49%)
At closeNov 10, 2026, 4:00 PM EST
40.58 -0.33 -0.81%
After hours · Nov 10, 4:00 PM ET
40.16 Day range 41.14
31.37 52-week range 50.88
- YTD
- -2.60%
- 1 year
- -0.22%
News
defenseworld.net Medline (NASDAQ:MDLN) Stock Has Average Target Price of $46.08 Shares of Medline (NASDAQ: MDLN - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the twenty-nine ratings firms that are covering the firm, MarketBeat.com reports.…
benzinga.com UBS Maintains Buy on Medline, Raises Price Target to $49 UBS analyst Kevin Caliendo maintains Medline (NASDAQ:MDLN) with a Buy and raises the price target from $43 to $49.
benzinga.com Citigroup Maintains Buy on Medline, Raises Price Target to $47 Citigroup analyst Joanne Wuensch maintains Medline (NASDAQ:MDLN) with a Buy and raises the price target from $45 to $47.
benzinga.com Leerink Partners Maintains Outperform on Medline, Raises Price Target to $46 Leerink Partners analyst Michael Cherny maintains Medline (NASDAQ:MDLN) with a Outperform and raises the price target from $43 to $46.- benzinga.com Evercore ISI Group Maintains Outperform on Medline, Raises Price Target to $44 Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform and raises the price target from $38 to $44.
marketbeat.com Medline Q3 Earnings Call Highlights Medline NASDAQ: MDLN reported third-quarter revenue growth of 10% year over year to $7.9 billion, supported by broad-based gains across its Medline Brand and Supply Chain Solutions businesses.…
benzinga.com Medline Q3 2026 Earnings Call Transcript Medline (NASDAQ:MDLN) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com Medline (MDLN) Reports Q3 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Medline (MDLN) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics…
benzinga.com Wayfair, Lendingtree, Bruker, Zimmer Biomet And Other Big Stocks Moving Higher On Wednesday U.S. stocks surged, led by Wayfair after strong results; Cricut, Array Technologies, Clear Secure and others also posted double-digit gains.
benzinga.com Medline Announces $1B Buyback Plan Medline Inc. ("Medline" or the "Company") (NASDAQ:MDLN), the largest provider of medical-surgical ("med-surg") products and supply chain solutions serving all points of care, today announced its- benzinga.com Medline Q3 Adj. EPS $0.44 Beats $0.35 Estimate, Sales $7.856B Beat $7.723B Estimate Medline (NASDAQ:MDLN) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.35 by 25.71 percent. The company reported quarterly sales of $7.856 billion which…
globenewswire.com Medline Reports Third Quarter and Nine Months 2026 Results NORTHFIELD, Ill., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions…
globenewswire.com MDLN Investigation Reminder: Medline Product Quality Issues Trigger Securities Fraud Investigation for Investors – Contact BFA Law if You Lost Money NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
benzinga.com ARM, McDonald's On Deck Wednesday As AI Demand, Consumer Spending Face Test ARM Holdings headlines Wednesday’s reports, with investors looking for evidence that AI-related demand can support the chip designer after a sharp stock pullback. McDonald’s, Novo Nordisk, Uber…
benzinga.com Earnings Volatility Watch: 10 Stocks Are Set to Swing More Than 10% This Week Ten stocks carry implied earnings moves above 10% next week, led by Moderna and AppLovin. Five are tech names hit in Friday's chip rout.- benzinga.com Mizuho Maintains Outperform on Medline, Lowers Price Target to $45 Mizuho analyst Steven Valiquette maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the price target from $48 to $45.